As concerns over sudden cardiac deaths among young adults gain traction, the Indian government and pharma leaders continue to assert the safety and efficacy of COVID-19 vaccines. However, a notable silence from private hospitals—key players in India’s vaccination drive—is raising questions.Lack of engagement is puzzling and a missed opportunity to educate and counter misinformation. In an era where trust in science must be actively upheld, public health communication demands not just official statements, but visible, united leadership.